Literature DB >> 21460014

Efficacy of antiamebic drugs in a mouse model.

Stephen Becker1, Paul Hoffman, Eric R Houpt.   

Abstract

Nitroimidazole antibiotics are the mainstay of treatment of invasive amebiasis; however, few comparative studies of applicable antibiotics are available. Evidence of sporadic clinical failure and rare reports of metronidazole resistance have led to the investigation of novel antiamebic therapeutics. The goal of this study was to examine drug efficacy in both in vitro and in vivo models of intestinal amebiasis. We studied six current and three novel drugs. Many drugs, including metronidazole, nitazoxanide, and nitazoxanide derivatives, were shown to be potently inhibitory in vitro. However, metronidazole remained the most effective in vivo, both in preventative and curative regimens, underscoring the value of animal models in evaluating future therapies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21460014      PMCID: PMC3062453          DOI: 10.4269/ajtmh.2011.10-0580

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  26 in total

Review 1.  Amebiasis.

Authors:  Rashidul Haque; Christopher D Huston; Molly Hughes; Eric Houpt; William A Petri
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

2.  Difficulties in the treatment of intestinal amoebiasis in mentally disabled individuals at a rehabilitation institution for the intellectually impaired in Japan.

Authors:  Tsukasa Fujishima; Shoichi Nishise; Masahiro Ichihara; Seiki Kobayashi; Tsutomu Takeuchi
Journal:  Chemotherapy       Date:  2010-08-18       Impact factor: 2.544

3.  Synthesis and antiparasitic activity of 2-(trifluoromethyl)-benzimidazole derivatives.

Authors:  G Navarrete-Vázquez; R Cedillo; A Hernández-Campos; L Yépez; F Hernädez-Luis; J Valdez; R Morales; R Cortés; M Hernández; R Castillo
Journal:  Bioorg Med Chem Lett       Date:  2001-01-22       Impact factor: 2.823

Review 4.  Experimental amoebiasis and the development of anti-amoebic compounds.

Authors:  R A Neal
Journal:  Parasitology       Date:  1983-02       Impact factor: 3.234

5.  Spectrum of disease and relation to place of exposure among ill returned travelers.

Authors:  David O Freedman; Leisa H Weld; Phyllis E Kozarsky; Tamara Fisk; Rachel Robins; Frank von Sonnenburg; Jay S Keystone; Prativa Pandey; Martin S Cetron
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

6.  The anti-amoebic activity of some medicinal plants used by AIDS patients in southern Thailand.

Authors:  Nongyao Sawangjaroen; S Phongpaichit; S Subhadhirasakul; M Visutthi; N Srisuwan; N Thammapalerd
Journal:  Parasitol Res       Date:  2006-01-31       Impact factor: 2.289

7.  Possible role of calcium ions, calcium channels and calmodulin in excystation and metacystic development of Entamoeba invadens.

Authors:  Asao Makioka; Masahiro Kumagai; Seiki Kobayashi; Tsutomu Takeuchi
Journal:  Parasitol Res       Date:  2002-06-04       Impact factor: 2.289

8.  Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model.

Authors:  Autumn S Downey; Curtis R Chong; Thaddeus K Graczyk; David J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

9.  Nitazoxanide in the treatment of amoebiasis.

Authors:  Jean-François Rossignol; Samir M Kabil; Yehia El-Gohary; Azza M Younis
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-07-20       Impact factor: 2.184

10.  In vitro activity of antiamoebic drugs against clinical isolates of Entamoeba histolytica and Entamoeba dispar.

Authors:  Devendra Bansal; Rakesh Sehgal; Yogesh Chawla; Ramesh Chander Mahajan; Nancy Malla
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-12-21       Impact factor: 3.944

View more
  10 in total

1.  Entamoeba histolytica-Encoded Homolog of Macrophage Migration Inhibitory Factor Contributes to Mucosal Inflammation during Amebic Colitis.

Authors:  Renay Ngobeni; Mayuresh M Abhyankar; Nona M Jiang; Laura A Farr; Amidou Samie; Rashidul Haque; Shannon N Moonah
Journal:  J Infect Dis       Date:  2017-04-15       Impact factor: 5.226

Review 2.  Understanding drug resistance in human intestinal protozoa.

Authors:  Hend Aly El-Taweel
Journal:  Parasitol Res       Date:  2015-03-19       Impact factor: 2.289

3.  In Vitro Testing of Potential Entamoeba histolytica Pyruvate Phosphate Dikinase Inhibitors.

Authors:  Syazwan Saidin; Nurulhasanah Othman; Rahmah Noordin
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

4.  Pyrazolo[3,4-d]pyrimidines as novel inhibitors of O-acetyl-L-serine sulfhydrylase of Entamoeba histolytica: an in silico study.

Authors:  Umesh Yadava; Bindesh Kumar Shukla; Mihir Roychoudhury; Devesh Kumar
Journal:  J Mol Model       Date:  2015-03-25       Impact factor: 1.810

Review 5.  Functionalized Nitroimidazole Scaffold Construction and Their Pharmaceutical Applications: A 1950-2021 Comprehensive Overview.

Authors:  Ria Gupta; Sumit Sharma; Rohit Singh; Ram A Vishwakarma; Serge Mignani; Parvinder Pal Singh
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-30

Review 6.  Tissue Destruction Caused by Entamoeba histolytica Parasite: Cell Death, Inflammation, Invasion, and the Gut Microbiome.

Authors:  Swagata Ghosh; Jay Padalia; Shannon Moonah
Journal:  Curr Clin Microbiol Rep       Date:  2019-01-21

Review 7.  Parasitic diarrheal disease: drug development and targets.

Authors:  Amir Azam; Mudasir N Peerzada; Kamal Ahmad
Journal:  Front Microbiol       Date:  2015-10-27       Impact factor: 5.640

8.  Atorvastatin: In-Vivo Synergy with Metronidazole as Anti-Blastocystis Therapy.

Authors:  Maha M A Basyoni; Shawky A Fouad; Marwa F Amer; Ahmed Fathy Amer; Dalia Ibrahim Ismail
Journal:  Korean J Parasitol       Date:  2018-04-30       Impact factor: 1.341

9.  Targeting Parasite-Produced Macrophage Migration Inhibitory Factor as an Antivirulence Strategy With Antibiotic-Antibody Combination to Reduce Tissue Damage.

Authors:  Swagata Ghosh; Jay Padalia; Renay Ngobeni; Jan Abendroth; Laura Farr; Debbie-Ann Shirley; Thomas Edwards; Shannon Moonah
Journal:  J Infect Dis       Date:  2020-03-16       Impact factor: 5.226

10.  COP9 signalosome is an essential and druggable parasite target that regulates protein degradation.

Authors:  Swagata Ghosh; Laura Farr; Aditya Singh; Laura-Ann Leaton; Jay Padalia; Debbie-Ann Shirley; David Sullivan; Shannon Moonah
Journal:  PLoS Pathog       Date:  2020-09-22       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.